Paradigm Shift in Cancer Research, Treatment and Education
نویسندگان
چکیده
منابع مشابه
The Paradigm Shift in Organizational Research
The creation and development of theory and methods used in the study of organizations is predominantly carried out grounded in the positivist paradigm – epistemological and methodological assumptions similar to those of the natural sciences. This essay looks at the limitations of that paradigm for the study of human organizations and the benefits of relativist, humanist and post-modern assumpti...
متن کاملICT-Enabled Education – Need for Paradigm Shift
Contemporary schools have not changed significantly since the 19th century. From primary level (elementary schools) to tertiary level of education (colleges and universities), the predominant approach to teaching is ex-cathedra teaching with assessment system based on grades. What has changed over the years are teaching and learning tools, but the methods have remained the same. In this context...
متن کاملFat Grafting Technique, A Paradigm Shift in the Treatment of Tuberous Breast
BACKGROUND The tuberous breast syndrome is a condition that affects young women and can bring on serious disorders of self-esteem. There are numerous surgical techniques to correct this condition, but most of them include the use of breast implants to replace lack of volume. Nowadays, patients are increasingly becoming more demanding to get a definitive solution with minimal aesthetic sequelae...
متن کاملa paradigm shift in glioblastoma treatment and research: a multi-mechanistic, multi-agent approach to target glioblastoma multiforme
the majority of patients with glioblastoma multiforme (gbm) suffer dismal outcomes. adopting a broader, multi-mechanistic, multi-agent approach targeting gbm using readily available and fairly benign agents in combination with standard therapy may improve outcomes. such agents include fluoxetine, fenofibrate, cimetidine, citrulline, valacyclovir, 1,3 1-6 beta glucan, and tadalafil, among others...
متن کاملParadigm-HF: a Paradigm Shift in Heart Failure Treatment?
DOI: 10.5935/abc.20160009 In the first semester of this year, the U.S. Food and Drug Administration (FDA) approved a new drug for the treatment of heart failure, LCZ696, commercially known as Entresto. This new treatment option was evaluated by the FDA on a priority basis (fast track designation), which allowed a faster release than usual. In Brazil, the drug is being evaluated by the National ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Juntendo Medical Journal
سال: 2014
ISSN: 2187-9737,2188-2126
DOI: 10.14789/jmj.60.199